MDM2 and colorectal cancer: For instance, TRIM59 promotes gastric carcinogenesis via interacting with p53 and promoting its ubiquitination and degradation (26); TRIM67 interacts with p53, resulting in inhibition of MDM2-mediated p53 degradation, finally activates p53 to suppress the initiation and progression in colorectal cancer (24).